Living Longer Around the World: Opportunities and Challenges

In April of 2022, Global Coalition on Aging (GCOA), in partnership with the Permanent Missions of Chile and the Republic of the Philippines, United Nations Department of Economic and Social Affairs (UNDESA), and the World Demographic & Ageing Forum (WDA Forum) Global Longevity Council, hosted an official side event of the 55th Session of the Commission on Population and Development at the United Nations in New York to launch “Living Longer Around the World: Opportunities and Challenges,” a new report authored by the WDA Forum Global Longevity Council. The report offers positions for policy makers and strategy planners based on age demographics to 2035 for 31 countries representing all levels of economic development, 70% of the global population, and 76% of global GDP.

The speakers from around the world included:

    • Chargé d’Affaires a.i, René Ruidíaz, Permanent Mission of Chile and Chair of the Group of Friends of Older Persons in New York
    • H.E. Mrs. Francisca Perales, Vice Minister of Social Services, Ministry of Social Development and Family of Chile
    • H.E. Ambassador Enrique A. Manalo, Permanent Representative of the Republic of the Philippines, Chair of the Bureau of the 55th Commission on Population and Development
    • H.E. Ambassador Boštjan Malovrh, Permanent Representative of Slovenia to the United Nations
    • Dr. Hans Groth, Chair of the World Demographic & Ageing (WDA) Forum
    • Dr. Pol Vanderbroucke, Chair of the WDA Forum Global Longevity Council
    • Dr. Yosuke Kita, Counselor, Permanent Mission of Japan to the United Nations
    • Ms. Bernardita Canals, Consultant at National Service for the Elderly Adults (SENAMA), Government of Chile
    • Dr. Karoline Schmid, Chief, Fertility and Population Ageing Section, Department of Economic and Social Affairs, Population Division
    • Dr. Nicholas Eberstadt, Henry Wendt Chair for Political Economy, American Enterprise Institute; Member, WDA Global Longevity Council
    • Dr. Gloria Langat, Aging and Development Unit, African Population and Health Research Centre, Kenya; Member, WDA Global Longevity Council

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

What Old Age Might Be Like for Today’s 30-Year-Olds

Get ready for a new old age. With the U.S. fertility rate in a decadelong slump and the life expectancy of 65-year-old Americans approaching roughly 85, our aging nation is likely to grow older by midcentury, as the ratio of young to old continues to decline. The trend is likely to upend how our society is organized, making life very different for today’s 30-year-olds when they reach their 60s compared with life for 60-year-olds now.

World Population Reaches 8bn As It Grows Older

The world’s population reached 8bn people on Tuesday and will hit 9bn in 15 years as it experiences an unprecedented surge in the number of older people, according to the latest UN data. The global fertility rate has more than halved since the 1950s to 2.3 births per woman. With mortality also falling, the number of people aged 65 and over is expected to rise from 783mn in 2022 to 1bn by 2030 and reach 1.4bn by 2043, the UN population data revealed.

Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships.

Japan Must Face Up to Growing Danger of Drug-resistant Germs

In the wake of more than 6.4 million COVID-19 deaths worldwide and unprecedented economic destruction, the global community has no excuse to be caught unprepared for the next pandemic. Yet right now, a devastating parallel plague is already underway and worsening. Some years, it is killing well over 1 million people, according to medical journal The Lancet.

A Bipartisan Bill Could Prevent The Next Pandemic

In Washington, Republicans and Democrats are typically at loggerheads when it comes to healthcare policy. Just consider the recent Inflation Reduction Act, which made extensive changes to Medicare and also extended Affordable Care Act subsidies. Every single congressional Democrat voted for the legislation, while every single member of the GOP voted against it. But occasionally, a bill is such an obviously good idea, and so desperately needed, that it commands significant bipartisan support. The PASTEUR Act, co-sponsored by 31 Democrats and 31 Republicans in the House and two members of each party in the Senate, is just such a bill.

Korea Must Act Now to Combat Growing AMR Threat

Public officials are overlooking one of the gravest long-term threats to the Korean people, the health system, and economy: antimicrobial resistance (AMR). Some pathogens ― bacteria, fungi, parasites, and viruses ― have evolved strains that resist the antimicrobial medications we currently have available to fight them. Health care professionals often must watch helplessly as patients succumb to infections that antibiotics could once have easily beaten. They know that new antimicrobials, including and especially antibiotics, could easily gain the victory ― but they have none at their disposal.

Policy Statement on the Impact of Price Negotiations on Innovation, Healthy Aging and Equity

As the CEO of the Global Coalition on Aging (GCOA) and a newly formed cross-sector Alliance for Health Innovation, we write to express our deep concern with the current legislation that allows for price “negotiations” in Medicare – a thinly veiled signal for America’s plunge into price controls that will have a devastating and adverse impact on biopharmaceutical innovation and our nations’ ability to support healthy aging.